Search results
Results From The WOW.Com Content Network
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
Many investors define successful investing as beating the market average over the long term. But the risk of stock...
For premium support please call: 800-290-4726 more ways to reach us
On September 20, 2001, in the middle of a 2–2 game between the Philadelphia Flyers and New York Rangers, the game was stopped. A message from United States President George W. Bush about the September 11 attacks was broadcast on the arena video screen.
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Across the first two days of August, the S&P 500 ( ^GSPC) slid 3.2% while the Nasdaq Composite ( ^IXIC) sank 4.7%. The moves extended a previous drawdown in the Nasdaq, with the index entering a ...
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
The stock market this week had a scary day on Monday and a great day on Thursday. Temporary declines are a normal part of the stock market's cycle. Long-term investments in the market generally ...